Le Lézard
Classified in: Health
Subjects: RCL, CFG

Advisory - Regener-Eyes Ophthalmic Solution and Regener-Eyes Ophthalmic Solution Lite recalled because of serious health risks


OTTAWA, ON, Oct. 30, 2020 /CNW/ -

Product: Regener-Eyes Ophthalmic Solution and Regener-Eyes Ophthalmic Solution Lite (biologic eye drops)
Issue: These unauthorized products claim to contain human placenta materials. Health Canada has not authorized any health products containing human placenta in Canada and they may pose serious health risks.
What to do: Do not use Regener-Eyes Ophthalmic Solution or Regener-Eyes Ophthalmic Solution Lite. Report any health product-related adverse reactions or complaints to Health Canada.

Health Canada is advising Canadians not to use the unauthorized biologic eye drops Regener-Eyes Ophthalmic Solution or Regener-Eyes Ophthalmic Solution Lite, which claim to contain human placenta materials. Health Canada has not authorized any health product containing human placenta in Canada and they may pose serious health risks.

Human placenta is a biologic material and can contain infectious agents such as bacteria (e.g. Group B Streptococcus) and viruses (e.g. HIV or hepatitis).

These eye drops have been found at various locations in Canada, and the Department has previously warned about this issue. A list of products and recalling companies is provided in the table of Affected Products below.

Health products that have not been authorized by Health Canada have not been assessed for safety, efficacy and quality, and could pose serious health risks.

Healthcare professionals should stop prescribing or dispensing Regener-Eyes Ophthalmic Solution and Regener-Eyes Ophthalmic Solution Lite immediately.

The Department is advising Canadians to:

What Health Canada is doing
Health Canada has directed companies to stop importing and selling these unauthorized products. The Department has also directed them to recall Regener-Eyes Ophthalmic Solution and Regener-Eyes Ophthalmic Solution Lite and to notify their clients immediately.

Should any additional recalls be necessary, Health Canada will update the Affected Products table on this page and inform Canadians.

Health Canada is sharing information with the provincial and territorial optometric regulatory bodies for further action as appropriate.

Health Canada will continue to take action against any companies found to be selling unauthorized health products either online or in stores in Canada. The Department works with the Canada Border Services Agency to help prevent the import of any unauthorized health products and will continue to warn Canadians about these products when they are found in the marketplace. Health Canada works closely with law enforcement agencies and may refer suspected illegal activity to them for further action.

Affected Products:

This list will be updated if more companies are found to be selling these eye drops.

Unauthorized health products

Product

Hazard Identified

Recalling Company

Action Taken

Date added

Regener-Eyes Ophthalmic Solution

Product claims to contain human placenta

Toronto Eye Care

55 Bloor Street West

Manulife Centre
Concourse L

Toronto, ON

M4W 1A5

Product recalled as it is not authorized for sale in Canada

October 30, 2020

Regener-Eyes Ophthalmic Solution

Product claims to contain human placenta

Calgary Trail Vision Centre

4620 Calgary Trail NW

Edmonton, AB

T6H 6A1

 

Product recalled as it is not authorized for sale in Canada

October 4, 2020

Regener-Eyes Ophthalmic Solution;

Regener-Eyes Ophthalmic Solution Lite

Product claims to contain human placenta

Haber's Compounding Pharmacy

1584 Bathurst Street

Toronto, ON

M5P 3H3

Product recalled as it is not authorized for sale in Canada

October 30, 2020

Regener-Eyes Ophthalmic Solution

Product claims to contain human placenta

Okotoks Eyecare

303-201 Southridge Drive

Okotoks, AB

T1S 2E1

Product recalled as it is not authorized for sale in Canada

October 30, 2020

 Également disponible en français

SOURCE Health Canada


These press releases may also interest you

19 avr 2024
Remedium Healthcare Products is proud to announce the launch of NuVeria Labs' revolutionary Sacral Silicone Dressing, now available for purchase on Amazon, bringing advanced wound care solutions directly to consumers' doorsteps. Designed to address...

19 avr 2024
Getting specialty medications into...

19 avr 2024
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards. "This product, along with our other innovations,...

19 avr 2024
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...

19 avr 2024
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

19 avr 2024
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...



News published on and distributed by: